Where Will Pfizer Stock Be in 3 Years?
Investors should always consider the long game when looking at stocks. Even if a business is not doing well right now, that doesn't mean it'll always be the case. Looking at a broader time frame can help you identify promising long-term buys.
One stock that is an intriguing one to consider is Pfizer (NYSE: PFE). These days, it hasn't been a hot stock to own, not by any stretch. Investors are worried about its growth. Its recent results haven't been impressive, and while the dividend offers a high yield, there may be concerns about it as well. The result has been a stock that's been in deep trouble: in five years, Pfizer's stock has declined by close to 30%.
Below, I'll look at where the business might be in the next three years, and whether it's worth investing in the healthcare stock today.
Source Fool.com
Pfizer Inc. Aktie
Die Community zeigt eine Präferenz für Buy-Einschätzungen bei Pfizer Inc..
Das Kursziel von 29 € für Pfizer Inc. impliziert eine deutliche Steigerung um über 20% gegenüber 23.14 €.
